Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: J Econ Behav Organ. 2016 Dec 2;134:27–47. doi: 10.1016/j.jebo.2016.11.011

Table 5.

Change in Treatment and Survival: Above vs. Below Median Age Patients

Above Median Age Patients Below Median Age Patients

Mean Prior to Jan 2005 +/− 11 Months +/− 9 Months Mean Prior to Jan 2005 +/− 11 Months +/− 9 Months
Share of Patients Receiving Chemotherapy Treatment within 1 month…
 In Physician’s office 0.094 0.014 (0.002) 0.016 (0.002) 0.164 0.024 (0.004) 0.023 (0.004)
 In Physician’s Office excl. Carboplatin 0.039 0.013 (0.002) 0.014 (0.002) 0.065 0.019 (0.002) 0.017 (0.002)
 In outpatient hospital 0.018 −0.001 (0.001) −0.001 (0.001) 0.036 0.003 (0.001) 0.004 (0.002)
 All settings 0.119 0.014 (0.002) 0.014 (0.003) 0.210 0.024 (0.003) 0.020 (.003)
Share of Patients Dying Within…
 3 months of diagnosis 0.397 −0.023 (0.006) −0.024 (0.005) 0.285 −0.0059 (0.0035) −0.0063 (0.0036)
 6 months of diagnosis 0.530 −0.029 (0.004) −0.032 (0.005) 0.411 −0.015 (0.002) −0.020 (0.0023)
 9 months of diagnosis 0.588 −0.026 (0.003) −0.031 (0.004) 0.470 −0.012 (0.003) −0.017 (0.003)
 1 year of diagnosis 0. 675 −0.015 (0.002) −0.018 (0.003) 0.567 0.002 (0.003) −0.006 (0.0038)
Observations (weeks) 48 96 72 48 96 72

Notes: Means in column 1 and 4 are for the dependent variable for patients above versus below the median age patient at diagnosis in the period prior to the reform, Feb–Nov 2004. See notes to Table 3 for other details.